Post date: 1 month 4 weeks ago

ISMP has identified the top three medication errors and hazards that were recurring themes in the acute care newsletter in 2023 and can be avoided or minimized with system and/or practice changes. See this week’s featured newsletter article for prevention strategies:

Post date: 2 months 1 hour ago

Increased demand and shortages of GLP-1 receptor agonists to aid in weight loss has led to reported errors with compounded versions of these drugs. For safe practice recommendations:

Post date: 2 months 2 days ago

Sign up now for the next MSOS Member Briefing webinar scheduled to be held on Thursday, March 28, 2024 from 1:00-2:00 PM ET. Register Now:
Short medication safety-related presentations for this webinar will include:

• What Did You Mean? Instructions on Prescriptions
Mariam Gawdat, PharmD, MS
FDA/ISMP Safe Medication Management Fellow

• Simulation Medications, the Risk is “Real”
Mara Weber, PharmD, BSRT
Medication Safety Pharmacist
OhioHealth- Doctor’s Hospital

• Federal Funding Opportunities for Medication Safety Research
Farzana Samad, PharmD, FISMP
Health Science Administrator
Agency for Healthcare Research and Quality

• ISMP Update
Rita K. Jew, PharmD, MBA, BCPPS, FASHP
President, ISMP

Post date: 2 months 6 days ago

Patient Safety Awareness Week is a good time to assess how your organization is applying ISMP’s 2024-2025 Targeted Medication Safety Best Practices for Hospitals. Please participate in our online survey to establish a baseline measurement of current level of implementation—deadline is April 19, 2024:

Post date: 2 months 1 week ago

Drug diversion can involve high-value non-controlled medications, such as those used to treat cancer or symptoms of opioid use. This week’s featured article provides recommendations for incorporating medications beyond controlled substances in diversion response programs: